Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GARDASIL Vaccination”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Post-approval studies (Phase 4)Active Not RecruitingNCT03943875
What this trial is testing

GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose

Who this might be right for
ImmunizationEfficacyHuman Papilloma Virus
The University of Texas Medical Branch, Galveston 767
Large-scale testing (Phase 3)Study completedNCT03728881
What this trial is testing

Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial

Who this might be right for
Human Papillomavirus-Related Cervical Carcinoma
National Cancer Institute (NCI) 1,240
Large-scale testing (Phase 3)Study completedNCT00813319
What this trial is testing

Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females

Who this might be right for
Vaccination
Emory University 216
Post-approval studies (Phase 4)Active Not RecruitingNCT05557370
What this trial is testing

Immunogenicity of HPV Vaccine in Transplant Recipients.

Who this might be right for
Chronic Kidney DiseasesKidney Transplant
Medical College of Wisconsin 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT03947775
What this trial is testing

HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL

Who this might be right for
Anal Intraepithelial NeoplasiaAnal CancerHuman Papilloma Virus
University Health Network, Toronto 228
Very early researchActive Not RecruitingNCT05329961
What this trial is testing

Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old

Who this might be right for
Human Papilloma Virus
Boston Medical Center 155
Not applicableStudy completedNCT01343485
What this trial is testing

Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

Who this might be right for
GARDASIL Vaccination
Planned Parenthood Federation of America 365
Not applicableEnded earlyNCT06229353
What this trial is testing

Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department

Who this might be right for
Human Papilloma Virus
University of Alabama at Birmingham 34
Not applicableEnded earlyNCT01276184
What this trial is testing

Effectiveness of SMS (Short Message Service) Text Messaging in Increasing Adherence to Gardasil

Who this might be right for
HPV Vaccines
University of Maryland, Baltimore 22
Not applicableStudy completedNCT02464358
What this trial is testing

An Information-Motivation-Behavioral Skills (IMB) Intervention to Promote Human Papillomavirus Vaccination Among Women

Who this might be right for
Human Papillomavirus Infection
University of Connecticut 70
Post-approval studies (Phase 4)Not Yet RecruitingNCT07256912
What this trial is testing

A Trial to Establish Non-inferiority of Immunogenicity of a Single-dose of CERVAVAC® Quadrivalent HPV Vaccine Compared to the Gardasil® Quadrivalent Vaccine Among Girls and Boys Aged 9 to 14 Years and in Girls/Women Aged 15 to 20 Years in Zambia

Who this might be right for
Vaccine EffectivenessHPV VaccinationSingle Dose+3 more
International Agency for Research on Cancer 1,266
Early research (Phase 1)Study completedNCT01092195
What this trial is testing

Gardasil Vaccination in Post Stem Cell Transplant Patients

Who this might be right for
Gardasil VaccineStem Cell TransplantImmunogenicity
National Heart, Lung, and Blood Institute (NHLBI) 64
Post-approval studies (Phase 4)Looking for participantsNCT05672927
What this trial is testing

Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

Who this might be right for
ImmunizationHPV InfectionHuman Papillomavirus
The University of Texas Medical Branch, Galveston 618
Not applicableStudy completedNCT00730704
What this trial is testing

Acceptance of Human Papillomavirus Vaccination in Postpartum Women

Who this might be right for
Human Papilloma VirusHPVPost Partum
Columbia University 150
Testing effectiveness (Phase 2)Study completedNCT00680147
What this trial is testing

Human Papillomavirus (HPV) Vaccination Acceptance by African-American Parents: Identifying Psychosocial Barriers

Who this might be right for
HPV
Syracuse University 614
Post-approval studies (Phase 4)Study completedNCT01101750
What this trial is testing

Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?

Who this might be right for
Cervical CancerHpvWarts
Medstar Health Research Institute 25
Not applicableUnknownNCT05658198
What this trial is testing

Investigating HPV Vaccination Uptake in Adults Aged 18-35 Seeking Care at a Health Clinic in Rural Mississippi

Who this might be right for
Human Papillomavirus Vaccination
Plan A Health, Inc 100
Post-approval studies (Phase 4)Study completedNCT02087384
What this trial is testing

HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)

Who this might be right for
AINHIV
Prof. Jan Prins 126
Testing effectiveness (Phase 2)Study completedNCT01928225
What this trial is testing

Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL

Who this might be right for
Cervical High Grade Squamous Intraepithelial Lesion
University of Witwatersrand, South Africa 180
Post-approval studies (Phase 4)Active Not RecruitingNCT04206813
What this trial is testing

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

Who this might be right for
HPV Infection
Boston Medical Center 352
Load More Results